4.7 Article Proceedings Paper

Prognostic factors and outcome of recurrence in childhood acute myeloid leukemia

期刊

CANCER
卷 109, 期 1, 页码 157-163

出版社

JOHN WILEY & SONS INC
DOI: 10.1002/cncr.22385

关键词

acute myeloid leukemia; recurrence; childhood

类别

资金

  1. NCI NIH HHS [P30 CA-21765] Funding Source: Medline
  2. NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER

向作者/读者索取更多资源

BACKGROUND. Outcome after recurrence of childhood acute myeloid leukemia (AML) is poor. We performed this study to identify prognostic factors for recurrence and for survival after recurrence of AML. METHODS. The clinical characteristics, biological features, treatment modalities, and outcomes of children with de novo AML who were enrolled on 3 consecutive clinical protocols from 1987 to 2002 at St. Jude Children's Research Hospital were studied. Regression modeling was used to identify prognostic factors for recurrence and for survival after recurrence. RESULTS. The outcome after recurrence was poor, with a 5-year survival estimate of only 23.3% +/- 5.7%. Multivariable analysis indicated that male sex (P = .005), autologous stem cell transplant before recurrence (P = .097), each additional month from diagnosis to recurrence (P = .041), and stem cell transplant after recurrence (P < .001) were associated with a better survival after recurrence, whereas M5 or M7 rnorphology (P = .001) were significantly predictive of a lower survival estimate after recurrence. CONCLUSION. Survival after recurrence was poor in children with AML. Novel therapies are urgently needed to prevent or to treat recurring AML. Cancer 2007;109:157-63. (c) 2006 American Cancer Society.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据